Exact Sciences Corp (NAS:EXAS)
$ 53.6 0.08 (0.15%) Market Cap: 9.89 Bil Enterprise Value: 11.77 Bil PE Ratio: 0 PB Ratio: 3.15 GF Score: 78/100

Exact Sciences Corp at Jefferies London Healthcare Conference Transcript

Nov 21, 2019 / 10:40AM GMT
Release Date Price: $79.02 (-5.85%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. We'll go ahead and get started. Thanks. Good morning. Welcome to Jefferies' 2019 London Healthcare Conference. I'm Brandon Couillard. I cover the life science, tools and diagnostics sector here at the firm. Very happy to have Exact Sciences with us back at the conference this year.

And here to share an update with us, Mr. Jeff Elliott, CFO; as well as Megan Jones, who heads up the IR, in the audience with us as well.

I'll turn it over to Jeff to make a few intro remarks and then we'll jump to the Q&A. Jeff?

Jeffrey T. Elliott
Exact Sciences Corporation - CFO

Thank you, Brandon. It's great to be back here, and thank you all for coming. Before we begin, a few quick words from our attorneys here, who find a way to fit 2,000 words under one slide.

At Exact, we're focused on the early detection and prevention of cancer. The reason why that's so important is that in cancer, many companies are focused on the end stages of life. Oftentimes, cancer drugs

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot